Eli Lilly Corp. buy Guggenheim
Start price
26.05.25
/
50%
€638.30
Target price
26.05.26
-
Performance (%)
23.91%
Price
10:05
€790.90
Summary
This prediction is currently active. The prediction currently has a performance of 23.91%. This prediction currently runs until 26.05.26. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Eli Lilly Corp. | -2.588% | -2.588% |
| iShares Core DAX® | 3,02 % | 2,20 % |
| iShares Nasdaq 100 | 3,56 % | 1,33 % |
| iShares Nikkei 225® | 6,62 % | 5,71 % |
| iShares S&P 500 | 2,64 % | 1,01 % |
Comments by Guggenheim for this prediction
In the thread Eli Lilly Corp. diskutieren
Eli Lilly and Company (NYSE: LLY) had its "buy" rating re-affirmed by analysts at Guggenheim.
Ratings data for LLY provided by MarketBeat
Stopped prediction by Guggenheim for Eli Lilly Corp.
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€844.20
16.08.24
16.08.24
€935.65
16.08.25
16.08.25
-28.93%
17.08.25
17.08.25
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€706.60
05.08.24
05.08.24
€806.83
05.08.25
05.08.25
-6.30%
06.08.25
06.08.25